APGE news · APGE stock

ABBV Stock Trading Above 50- & 200-Day SMAs: Buy, Hold or Sell?

Yahoo Finance · Sep 3, 2026 · Apogee Therapeutics, Inc. Common Stock (APGE)

AbbVie's Skyrizi, Rinvoq and neuroscience drugs drive growth, but Humira erosion, oncology and Aesthetics remain key headwinds.

Original at Yahoo Finance

Not investment advice. Cached headline, not a full reprint.